| All patients (n = 5469) | Group 1 (n = 3804) | Group 2 (n = 1544) | Group 3 (n = 121) | P Value |
---|---|---|---|---|---|
Baseline characteristics | |||||
 Age (y), mean (SD) | 64.6 ± 12.1 | 62.9 ± 11.9 | 68.7 ± 11.7 | 69.4 ± 10.6 |  < 0.001 |
 Female, n (%) | 2300 (42.1) | 1517 (39.9) | 726 (47.0) | 57 (47.1) |  < 0.001 |
 Body weight(kg), mean (SD) | 66.1 ± 12.2 | 67.7 ± 12.2 | 62.7 ± 11.5 | 58.9 ± 11.6 |  < 0.001 |
 CHA2DS2-VASc score, mean (SD) | 2.2 ± 1.6 | 2.0 ± 1.5 | 2.7 ± 1.6 | 2.3 ± 1.4 |  < 0.001 |
 HAS-BLED score, mean (SD) | 1.4 ± 1.0 | 1.3 ± 1.0 | 1.6 ± 1.0 | 1.5 ± 1.0 |  < 0.001 |
Past medical history, n (%) | |||||
 COPD | 109 (2.0) | 53 (1.4) | 52 (3.4) | 4 (3.3) |  < 0.001 |
 Coronary heart disease | 476 (8.7) | 262 (6.9) | 199 (12.9) | 15 (12.4) |  < 0.001 |
 Congestive heart failure | 278 (5.1) | 141 (3.7) | 122 (7.9) | 15 (12.4) |  < 0.001 |
 Chronic kidney disease | 338 (6.2) | 195 (5.1) | 132 (8.5) | 11 (9.1) |  < 0.001 |
 Hypertension | 2988 (54.6) | 2016 (53.0) | 921 (59.7) | 51 (42.1) |  < 0.001 |
 Diabetes mellitus | 1032 (18.9) | 687 (18.1) | 326 (21.1) | 19 (15.7) | 0.023 |
 Previous stroke | 205 (3.7) | 104 (2.7) | 97 (6.3) | 4 (3.3) |  < 0.001 |
 Gout | 94 (1.7) | 47 (1.2) | 44 (2.8) | 3 (2.5) |  < 0.001 |
 Malignancy | 77 (1.4) | 35 (0.9) | 37 (2.4) | 5 (4.1) |  < 0.001 |
Baseline laboratory data, mean(SD) | |||||
 ALT, IU/L | 27.3 ± 40.0 | 27.7 ± 38.6 | 26.2 ± 43.7 | 27.6 ± 32.9 | 0.488 |
 CrCl, mL/min | 74.3 ± 30.7 | 78.5 ± 30.4 | 65.0 ± 29.1 | 59.4 ± 28.5 |  < 0.001 |
Baseline medications, n (%) | |||||
 Dabigatran | 2548 (46.6) | 1861 (48.9) | 638 (41.3) | 49 (40.5) |  < 0.001 |
   110 mg/bid | 2469 (45.1) | 1796 (47.2) | 624 (40.4) | 49 (40.5) |  < 0.001 |
   150 mg/bid | 79 (1.4) | 65 (1.7) | 14 (0.9) | 0 (0) | 0.034 |
 Rivaroxaban | 2921 (53.4) | 1943 (51.1) | 906 (58.7) | 72 (59.5) |  < 0.001 |
   10 mg/qd | 790 (14.4) | 427 (11.2) | 334 (21.6) | 29 (24.0) |  < 0.001 |
   15 mg/qd | 1986 (36.3) | 1407 (37.0) | 540 (35.0) | 39 (32.2) | 0.245 |
   20 mg/qd | 145 (2.7) | 109 (2.9) | 32 (2.1) | 4 (3.3) | 0.237 |
 ACEI/ARB | 2380 (43.5) | 1659 (43.6) | 677 (43.8) | 44 (36.4) | 0.272 |
 Amiodarone | 962 (17.6) | 714 (18.8) | 229 (14.8) | 19 (15.7) | 0.002 |
 Beta-blocker | 3484 (63.7) | 2449 (64.4) | 958 (62.0) | 77 (63.6) | 0.275 |
 CCB | 1641 (30.0) | 1152 (30.3) | 456 (29.5) | 33 (27.3) | 0.693 |
 Diltiazem | 768 (14.0) | 529 (13.9) | 224 (14.5) | 15 (12.4) | 0.738 |
 Digoxin | 570 (10.4) | 373 (9.8) | 187 (12.1) | 10 (8.3) | 0.032 |
 Statins | 2729 (49.9) | 1872 (49.2) | 789 (51.1) | 68 (56.2) | 0.171 |